SCHEMBL17847313

SCHEMBL17847313

CCc1ccc(N(CC(C)C)S(=O)(=O)c2ccc(N)c([N+](=O)[O-])c2)cc1

nearest known ligand 0.53

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.53
ALDH1A1 P00352 1/20 0.53
POLB P06746 1/20 0.53
PKM P14618 1/20 0.53
KMT2A Q03164 1/20 0.53
RORC P51449 19/20 0.51
IL17A Q16552 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17843833 0.87 VCAM1 (0.59) MEN1ALDH1A1KMT2ARORCIL17A
SCHEMBL17858289 0.86 RORC (0.52) RORCIL17A
SCHEMBL17843345 0.84 RORC (0.49) RORCIL17A
SCHEMBL17843945 0.80 RORC (0.56) RORCIL17A
SCHEMBL17858304 0.79 RORC (0.55) RORCIL17A
SCHEMBL17852447 0.78 RORC (0.54) RORCIL17A
SCHEMBL17843316 0.78 RORC (0.50) RORCIL17A
SCHEMBL17843315 0.78 RORC (0.50) RORCIL17A
SCHEMBL17843934 0.78 RORC (0.61) RORCIL17A
SCHEMBL20677666 0.77 RORC (0.51) RORCIL17A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016097394-A1 BICYCLIC SULFONAMIDE DERIVATIVES AS INVERSE AGONISTS OF RETINOID-RELATED ORPHAN RECEPTOR GAMMA (ROR GAMMA (T)) GALDERMA RESEARCH & DEVELOPMENT (FR) 2016-06-23 WO disclosed
WO-2016097394-A1 BICYCLIC SULFONAMIDE DERIVATIVES AS INVERSE AGONISTS OF RETINOID-RELATED ORPHAN RECEPTOR GAMMA (ROR GAMMA (T)) GALDERMA RESEARCH & DEVELOPMENT (FR) 2016-06-23 WO disclosed